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Discussion /	Conclusion
Our data reinforces the idea that neoad juvant CRT contribute d to tumor shr inkage, as is documented by
the number of positive pR. This would in turn lead to higher R0 rates, TNMdownstaging and longer survival.
We achieved surgery resu lts and treatment outcomes simi lar to h igher-volume centers. Since most of the
patients have le sst han3 years fo llow-up, we expect that the overall and disea se free surv ivaloutcomes wi ll
improve.










Middle Third 12 32,4%






Esophageal cancer is a devastating d isease ,
associated with a poor progno sis. Neoad juvant
Chemo-Radiotherapy (CRT) a ims to reduce the
bulk of the primary tumor before surgery in or der
to facilitate highe r curative resection rates ,
achieve better locorregional control and prevent
micrometastasis.
We pre sent the results of a trimoda l approach
performed by a medium-volume multid iscipl inary
unit.
Material	/	Methods
We performed a retrospective review of 37
consecutive patients who receivedesophagectomy
after neoadjuvant CRT between March 2003 and
March 2016 at the Unidade de Patologia Esófago-












Table 3.	LymphNode	 (LN) Dissection Results
Total	 LN	Ressected 771
LN Per Patient (Median) 20
≥	15	LN 26	patients
≥	25	LN 13	patients










Partial Response 21 56,8%
Complete Response 8 21,6%
Positive	 pR 29 78,4%
Table 7.	Survival Outcomes
Overall Survival
Median Survival Time	(months) 33
Disease Free	Survival




≤ 30 days 10 27,0%
>	30	days 3 8,1%











Acute mesenteric ischemia (✝) 1
Table 2.	Surgery Results
ypTNMStage
0 7 18,9%
I 8 21,6%
II 9 24,3%
III 13 35,1%
Ressection
R0 33 89,2%
R1 3 8,1%
R2 1 2,7%
68% 32% 16%
68% 32% 16%No
46%
1	Stage
27%
2	Stages
13%
3	Stages
14%
Yes
54%
